Go Back to Match Results for "trials"
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Ruxolitinib in Participants With COVID-19–Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
Recruitment Status
Enrolling By InvitationIf you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.
